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Abstract
Background: As a group of highly conserved small non-coding RNAs with a length of 21~23 nucleotides,
microRNAs (miRNAs) regulate the gene expression post-transcriptionally by base pairing with the partial or full
complementary sequences in target mRNAs, thus resulting in the repression of mRNA translation and the
acceleration of mRNA degradation. Recent work has revealed that miRNAs are essential for the development and
functioning of the skeletal muscles where they are. In particular, miR-206 has not only been identified as the only
miRNA expressed in skeletal muscles, but also exhibited crucial roles in regulation of the muscle development.
Although miRNAs are known to regulate various biological processes ranging from development to cancer, much
less is known about their role in the dynamic regulation of the mammalian circadian clock.
Results: A detailed dynamic model of miR-206-mediated mammalian circadian clock system was developed
presently by using Hill-type terms, Michaelis-Menten type and mass action kinetics. Based on a system-theoretic
approach, the model accurately predicts both the periodicity and the entrainment of the circadian clock. It also
explores the dynamics properties of the oscillations mediated by miR-206 by means of sensitivity analysis and
alterations of parameters. Our results show that miR-206 is an important regulator of the circadian clock in skeletal
muscle, and thus by study of miR-206 the main features of its mediation on the clock may be captured.
Simulations of these processes display that the amplitude and frequency of the oscillation can be significantly
altered through the miR-206-mediated control.
Conclusions: MiR-206 has a profound effect on the dynamic mechanism of the mammalian circadian clock, both
by control of the amplitude and control or alteration of the frequency to affect the level of the gene expression
and to interfere with the temporal sequence of the gene production or delivery. This undoubtedly uncovers a new
mechanism for regulation of the circadian clock at a post-transcriptional level and provides important insights into
the normal development as well as the pathological conditions of skeletal muscles, such as the aging, chronic
disease and cancer.
Background
Most organisms use circadian rhythms to keep the tem-
poral order and anticipate daily variations in their envir-
onmental changes [1]. Circadian rhythms are the
sustained oscillations occurring with a periodicity close
to 24 h in almost all living organisms from the cyano-
bacteria to plants, insects and mammals which are
innately generated by an internal timing mechanism, i.e.,
the so-called circadian clock. In mammals, the master
circadian clock is located in the suprachiasmatic nucleus
(SCN) of the ventral hypothalamus [2], where it orches-
trates the diurnal changes in both the physiology and
behavior. As such, the SCN is capable of generating
self-sustained rhythmicity in its intrinsic biological pro-
cesses. The mammalian circadian clock regulates many
bodily functions, such as the sleep-wake cycles, the neu-
roendocrine levels, mental alertness, physical strength,
renal and liver activity, body temperature, blood pres-
sure, blood viscosity and the release of appropriate hor-
mones at different times [3]. In addition to these widely
well-known effects, circadian rhythms also play a role in
the pathogenesis and guide the optimal treatment for
certain diseases including the arthritis, asthma, cancer,
cardiovascular disease, diabetes, duodenal ulcers,
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[4,5].
At the molecular level, molecular and genetic studies
indicate that a circadian period arises from a system of
interconnected feedback loops which control the tran-
scription of a small number of “clock” genes [6,7]. It is
intriguing that the mechanism of circadian rhythms
relies exactly on the interaction of these negative or
positive feedback loops, which has been proposed to be
important for generation of the basic circadian rhythm.
In other words, every oscillator has both positive and
negative elements to establish the feedback loop. The
positive elements of the loop activate the expression of
the negative elements, in which way moving a system
away from its equilibrium state and become more
unstable. Whereas, the negative elements feed back to
block their own activation (as induced by the positive
elements), which usually makes a system go into some
equilibrium state to become more stable. Importantly,
the key aspects of these feedback loops (including the
period and amplitude) can be modulated by the changes
in clock. Although the sustained circadian rhythms are
produced by the central pacemaker located in the SCN
of the anterior hypothalamus [8,9], peripheral tissues
such as liver, kidney or skeletal muscle can also give rise
to circadian rhythms [10]. Recent work also showed that
the clock timing and entrainment could be affected at a
post-transcriptional level [11]. Thus, it is important to
investigate the molecular basis of the post-transcrip-
tional, i.e., miRNA-mediated regulation of the circadian
timing both in the SCN and peripheral tissues.
MiRNAs are small non-coding RNAs, with approxi-
mately 22 nucleotides long that are involved in post-
transcriptional regulation of the gene expressions in
most living organisms. They are well conserved in
eukaryotic organisms and are thought to be vital and
evolutionarily ancient components of the genetic regula-
tion [12]. MiRNA molecules are partially complemen-
tary to one or more mRNA molecules, with a main
function of down-regulating the gene expression in a
variety of manners. They play a crucial role in diverse
biological processes during the normal development
such as the developmental timing and patterning, apop-
tosis, cell proliferation, organ development, as well as
the pathological responses like the tumorigenesis
[13,14]. However, up to now for most miRNAs, very lit-
tle is known regarding their functions and precise regu-
lation mechanisms. Thus, great efforts have been made
to discover novel miRNAs and to elucidate their regula-
tory mechanism in recent years.
Lately, a large fraction of miRNAs were found exhibit-
ing strict developmental stage and tissue-dependent
expression manner which is critical for their appropriate
activities [15], and the clock-relevant miRNAs are the
same cases. Sempere et al. proved that the canonical
myomiRs (myo = muscle + miR = miRNA) miR-1,
-133a and -206 are highly expressed in both human and
mouse heart and skeletal muscles [16]. And miR-206 is,
especially, specifically restricted to the skeletal muscle,
but is absent or expressed at relatively low levels in
other tissues, which is exactly the reason making itself a
unique one among the myomiR family [17-19]. MiR-206
reinforces the muscle differentiation program by redu-
cing the levels of DNA polymerase and the inhibitory
HLH protein Id, which functions as a negative regulator
of MyoD [20]. In addition, chromatin immunoprecipita-
tion experiments also demonstrated that the expression
of muscle-enriched miRNAs was controlled by the myo-
genic regulatory factors Myod1 and myogenin [21], two
key components of the core circadian clock. Indeed,
miR-206 was recently found to be a direct transcrip-
tional target of Myod1 [22], a muscle-specific regulator
that can stimulate the expression of miR-206. Despite of
the role as a clock-controlled gene, Myod1 was also a
constituent of the skeletal muscle circadian transcrip-
tome [23]. Up to now, the Clock gene is the only
reported miR-206 target involved in the circadian
mechanism [24]. Taken together, the unique exclusively
and highly expressed muscle-specific miRNA-206 might
represent an intriguing tool to regulate the circadian
rhythm process [25].
It is known that circadian clock system involves many
components and complex interactions in living organ-
isms [26]. Clearly, this complexity renders it extremely
difficult to intuitively understand the clock control
mechanism or even a simple configuration of those core
genes. To explore the specific effects of various genes
that control the circadian clocks, it is necessary to resort
to computational systems biology methods, which have
emerged as powerful tools to supplement the experi-
mental work and provide insights into the operation of
the gene networks. Traditionally, the modeling of che-
mical reactions can be achieved either by using differen-
tial equations built based on the law of mass action or
by the use of their stochastic counterpart [27,28]. The
modeling of circadian rhythms has also begun a long
time before as recently reviewed [29,30]. As a result,
many interesting properties of the rhythms have been
uncovered by the mathematical models, like the discov-
ery that there might exist multiple sources of periodic
behavior in the genetic regulatory network controlling
the circadian oscillations. Recently a new deterministic
model for study of the mammalian circadian clock has
been proposed [31]. This model was developed based on
incorporation of the intertwined positive and negative
regulatory loops involving the Per, Cry, Bmal1, Clock
and Rev-Erba genes, which account for the autono-
mous, sustained circadian oscillations in conditions
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importance of the miRNA regulation in circadian oscil-
lators has also been demonstrated in two dynamics
models recently reported [32].
However, up to now, little is known about the contri-
bution effects of the translational controls to the circa-
dian rhythms system. No further model for the
mammalian circadian clock involved in the miRNA-
mediated regulation mechanism has been developed,
particularly for the miR-206, a critical fine-tuner of the
core circadian clock. To address this issue and in parti-
cular to explore the translational control by miRNAs, in
the present work we attempt to establish a detailed
quantitative mathematical model for the circadian
rhythms oscillators in mammalian clock, which involves
a Clock-Myod1-miR-206 feedback loop controlling the
timing of the circadian cycle. The process includes sev-
eral aspects. Firstly, the generation of the basic circadian
rhythm in our model depends on two negative autore-
gulations of the gene expression. One is the negative
autoregulatory feedback exerted by the CLOCK-BMAL1
on the expression of Bmal1 gene. The other is the Clock
expression which is subjected to a negative autoregula-
tion by the CLOCK protein. Secondly, besides the nega-
tive autoregulatory feedback of the gene expression, the
interplay of the negative and positive feedback loops is
also taken into consideration. Actually, these interlocked
feedback loops potentially allow for multiple inputs and
outputs at different phases [33] and help to dissect their
differential roles in the system. As a result, a theoretical
model was developed in this work and the dynamic
mechanism it uncovered is well supported by several
recent experimental studies [34-37]. The model and
related discovery might be helpful for deep understand-
ing of the mechanism of miRNA-mediated circadian
rhythms. It points out the crucial role of the miRNA-
mediated control on the gene expression during the ske-
letal muscle development and disease, and considers the
potential of miRNAs as therapeutic targets.
Results and discussion
Dynamics of the pathway
Recent studies showed that the molecular mechanism of
circadian oscillations not only relies on the feedback
loops of the gene expression, but also is affected by the
interfering of miRNAs in the circadian rhythm choreo-
graphy [11]. Therefore, in this work, a miR-206-
mediated mammalian circadian clock model was devel-
oped and the properties of the oscillations involved in
the model were investigated which incorporated the
main components that play roles in the circadian
rhythms.
Using a set of parameters with appropriate biological
values, the modeling work was carried out presently
(Table 1) by numerical integration of Eqs. (1)-(19). The
reasonability of this model can be demonstrated by the
simulated periods of oscillations which are close to 24 h
in continuous darkness for those key components like
CLOCK protein. These oscillations are constant and
self-sustained ("built-in”) since the conditions of the
equations are constant in time. However, because some
parameter values remain to be determined experimen-
tally, the occurrence of autonomous sustained oscilla-
tions accounted by the model might suffer from a
semiarbitrary choice of parameter values. Despite of
this, the model we developed still yields a period of
oscillations in continuous darkness close to 24 h, as all
these parameters are within a reasonable physiological
range (Table 1). The observed dynamics of the clock
system are well consistent with the general principle
that the circadian rhythms in mammals can persist in
continuous darkness or light [38].
Figure 1 shows the obtained results where the red
curves represent the oscillations with the regulation of
miR-206. With introduction of miR-206, we can see that
the oscillations of Bmal1 mRNA (MB), Myod1 mRNA
(Mmy) and Clock mRNA (MP)a r ea l lk e p tw i t hap e r i o d
of ~24 h (Figures 1A, C and 1E). The proteins follow
their mRNAs by a few hours which also go through
similar oscillations (Figures 1B, D and 1F). In addition,
the Bmal1 mRNA oscillates in phase with Myod1
mRNA, but in antiphase with Clock mRNA. These
results are in a good agreement with those experimental
observations [39,40], proving the reasonability of the
model. As we know, circadian rhythm in mammals can
generate sustained oscillations that are mainly produced
by the SCN, a pair of distinct groups of cells located in
the hypothalamus [8,9]. Other peripheral mammalian
tissues such as liver, heart, kidney and skeletal muscle
[10] can also generate circadian rhythms, leading to
endogenous and continuous rhythmic oscillations in
aperiodic physiological response. Besides, presently miR-
206 was also demonstrated to be a potentially novel ave-
nue by which the circadian timing processes in skeletal
muscle are regulated.
The black curves of Figure 1 representing those
oscillations of the system in the absence of miR-206
disclose some other interesting information. As seen
from the curves, obviously without the miR-206 regu-
l a t i o no n l yas u b t l ec h a n g ei so b s e r v e di nt h eo s c i l l a -
tory pattern of the system compared to the miR-206-
mediated case, indicating that the impact of miRNA
regulation on the oscillatory pattern formation in cir-
cadian rhythms may not be enormous. However, the
oscillatory appearance of some key components such
as Myod1 mRNA and its protein changes significantly,
with the amplitude increased by about 77% and 133%
(Figures 1C and 1D) respectively, but the increase in
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Parameter Definition Set1 Set2 Set3 Set4 Determination
k1(h
-1) Rate constant for entry of the BMAL1 protein into the nucleus 0.4 0.4 0.4 0.4 38
k2(h
-1) Rate constant for exit of the BMAL1 protein from the nucleus 0.2 0.2 0.2 0.2 38
k3(nM
-1·h
-1) Rate constant for the formation of the inactive IN complex 0.55 0.55 0.55 0.55 38
k4(h
-1) Rate constant for the dissociation of the IN complex 0.1 0.1 0.1 0.1 38
k5(h
-1) Rate constant for entry of the CLOCK protein into the nucleus 2.0 2.0 2.0 2.0 24
k6(h
-1) Rate constant for exit of the CLOCK protein from the nucleus 1.0 1.0 1.0 1.0 24
d1(nM·h
-1) Rate constant for the production of the Bmal1 3.6 3.6 3.6 3.6 38, 43
d2(h
-1) Maximum rate of Bmal1 degradation 0.9 0.9 0.9 0.9 38, 43
d3(nM·h
-1) Rate constant for the production of the Myod1 4.0 4.0 4.0 4.0 38, 43
d4(h
-1) Maximum rate of Myod1 degradation 0.9 0.9 0.9 0.9 38, 43
d5(nM·h
-1) Rate constant for the production of the Clock 4.0 4.0 4.0 4.0 38, 43
d6(h
-1) Maximum rate of Clock degradation 0.9 0.9 0.9 0.9 38, 43
KIB(nM) Inhibition constant for repression of Bmal1 expression by nuclear BMAL1 0.8 0.8 0.8 0.8 38
KI(nM) Inhibition constant for repression of Clock expression by nuclear CLOCK 2.0 2.0 2.0 2.0 24
KAM(nM) Activation constant for enhancement of miR-206 expression by MYOD1 2.0 2.0 2.0 2.0 24, 38
KAC(nM) Activation constant for enhancement of Myod1 expression by the IN complex 0.8 0.8 0.8 0.8 38
kdmb(h
-1) Nonspecific degradation rate constant for Bmal1 mRNA 0.01 0.01 0.01 0.01 38
kdmc(h
-1) Nonspecific degradation rate constant for Myod1 mRNA 0.12 0.12 0.12 0.12 38
kdnc(h
-1) Nonspecific degradation rate constant for cytosolic non-phosphorylated MYOD1 0.5 0.5 0.5 0.5 38
kdn1(h
-1) Nonspecific degradation rate constant for cytosolic dephosphorylated BMAL1 0.01 0.01 0.01 0.01 38
kdn2(h
-1) Nonspecific degradation rate constant for cytosolic phosphorylated BMAL1 0.01 0.01 0.01 0.01 38
kdn3(h
-1) Nonspecific degradation rate constant for nuclear dephosphorylated BMAL1 0.01 0.01 0.01 0.01 38
kdn4(h
-1) Nonspecific degradation rate constant for cytosolic phosphorylated MYOD1 0.01 0.01 0.01 0.01 38
kdn5(h
-1) Nonspecific degradation rate constant for IN complex 0.01 0.01 0.01 0.01 38
kdn6(h
-1) Nonspecific degradation rate constant for nuclear phosphorylated BMAL1 0.01 0.01 0.01 0.01 38
Kd1(nM) Michaelis constant for cytosolic phosphorylated BMAL1 degradation 0.3 0.3 0.3 0.3 38
Kd2(nM) Michaelis constant for nuclear phosphorylated BMAL1 degradation 0.3 0.3 0.3 0.3 38
Kd3(nM) Michaelis constant for cytosolic phosphorylated MYOD1 degradation 0.3 0.3 0.3 0.3 38
Kd4(nM) Michaelis constant for IN complex degradation 0.3 0.3 0.3 0.3 38
Kdp1(nM) Michaelis constant for cytosolic BMAL1 dephosphorylation 0.3 0.3 0.3 0.3 38
Kdp2(nM) Michaelis constant for nuclear BMAL1 dephosphorylation 0.3 0.3 0.3 0.3 38
Kdp3(nM) Michaelis constant for cytosolic MYOD1 dephosphorylation 0.3 0.3 0.3 0.3 38
Kp1(nM) Michaelis constant for cytosolic BMAL1 phosphorylation 0.1 0.1 0.1 0.1 38
Kp2(nM) Michaelis constant for nuclear BMAL1 phosphorylation 0.1 0.1 0.1 0.1 38
Kp3(nM) Michaelis constant for cytosolic MYOD1 phosphorylation 0.1 0.1 0.1 0.1 38
Kvd(nM) Michaelis constant for P2 degradation 0.1 0.1 0.1 0.1 24
K1(nM) Michaelis constant for P0 phosphorylation 1.5 1.5 1.5 1.5 24
K2(nM) Michaelis constant for P1 dephosphorylation 2.0 2.0 2.0 2.0 24
K3(nM) Michaelis constant for P1 phosphorylation 1.5 1.5 1.5 1.5 24
K4(nM) Michaelis constant for P2 dephosphorylation 2.0 2.0 2.0 2.0 24
KmB(nM) Michaelis constant for degradation of Bmal1 mRNA 0.4 0.4 0.4 0.4 38
KmC(nM) Michaelis constant for degradation of Myod1 mRNA 0.1 0.1 0.1 0.1 38
Km(nM) Michaelis constant for degradation of Clock mRNA 0.2 0.2 0.2 0.2 24
kstot (h
-1) Rate constant for protein synthesis 1.0 1.0 1.0 1.0 38
ksB(h
-1) Rate constant for synthesis of BMAL1 1.0kstot 1.0kstot 1.0kstot 1.0kstot 38
ksC(h
-1) Rate constant for synthesis of MYOD1 0.3kstot 0.3kstot 0.3kstot 0.3kstot 38
ks(h
-1) Rate constant for synthesis of CLOCK 2.0 2.0 2.0 2.0 24
m1 Degree of cooperativity of repression of Bmal1 expression by nuclear
dephosphorylation BMAL1
4.0 4.0 4.0 4.0 38
m2 Degree of cooperativity of repression of Clock expression by nuclear CLOCK 4.0 4.0 4.0 4.0 38
n1 Degree of cooperativity of activation of Myod1 expression by IN complex 4.0 4.0 4.0 4.0 38
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their proteins is less pronounced as approximately 10%
(Figures 1A, B, E and 1F).
T h es a m et e n d e n c yo b s e r v e di nF i g u r e1i sa l s op r o -
ven by Figure 2, which accurately depicts the expression
increase for those key components in the pathways with
or without the miR-206 regulations. Clearly, for several
crucial components like the Clock mRNA (MP), Bmal1
mRNA (MB), cytosolic and nuclear CLOCK proteins (P0,
P2, PN) and the complex between the nuclear CLOCK
and BMAL1 proteins (IN), only small variations in the
amplitude of the components are observed without the
miR-206 regulation. But for other components, like the
cytosolic CLOCK proteins (P1), Myod1 mRNA (Mmy)
and cytosolic MYOD1 (MYC), their expression levels are
largely enhanced in the absence of miRNA. This may be
due to the fact that MyoD is a direct target of the circa-
dian transcriptional activators IN,w h i c hb i n d si na
rhythmic manner to the core enhancer of the MyoD
promoter [41]. Therefore, the complex IN directly con-
trols the Mmy and MYC expression, which is more
important than the indirect miRNA regulation. These
results may be related to the fact that the transcription
and translation of key circadian core components, on
one hand are tightly connected with each other, and on
the other hand may buffer each other. Such a regulatory
Table 1 Basal parameter values yielding circadian oscillations in conditions corresponding to continuous darkness
(Continued)
n2 Degree of cooperativity of activation of miR-206 synthesis by cytosolic
dephosphorylation MYOD1
4.0 4.0 4.0 4.0 38
V1B(nM·h
-1) Maximum rate of cytosolic BMAL1 phosphorylation 1.0 1.0 1.0 1.0 38
V2B(nM·h
-1) Maximum rate of cytosolic BMAL1 dephosphorylation 0.1 0.1 0.1 0.1 38
V3B(nM·h
-1) Maximum rate of nuclear BMAL1 phosphorylation 1.0 1.0 1.0 1.0 38
V4B(nM·h
-1) Maximum rate of nuclear BMAL1 dephosphorylation 0.2 0.2 0.2 0.2 38
V1c(nM·h
-1) Maximum rate of cytosolic MYOD1 phosphorylation 1.0 1.0 1.0 1.0 38
V2c(nM·h
-1) Maximum rate of cytosolic MYOD1 dephosphorylation 0.5 0.5 0.5 0.5 38
V1(nM·h
-1) Maximum rate of cytosolic P0 phosphorylation 6.0 6.0 6.0 6.0 24
V2(nM·h
-1) Maximum rate of cytosolic P1 dephosphorylation 3.0 3.0 3.0 3.0 24
V3(nM·h
-1) Maximum rate of cytosolic P1 phosphorylation 6.0 6.0 6.0 6.0 24
V4(nM·h
-1) Maximum rate of cytosolic P2 dephosphorylation 3.0 3.0 3.0 3.0 24
VdBC(Nm·h
-
1)
Maximum rate of degradation of cytosolic phosphorylated BMAL1 1.0 1.0 1.0 1.0 38
VdBN(nM·h
-
1)
Maximum rate of degradation of nuclear phosphorylated BMAL1 1.0 1.0 1.0 1.0 38
Vdcc(nM·h
-
1)
Maximum rate of degradation of cytosolic phosphorylated MYOD1 0.1 0.1 0.1 0.1 38
VdIN(nM·h
-
1)
Maximum rate of degradation of IN complex 0.6 0.6 0.6 0.6 38
VmB(nM·h
-
1)
Maximum rate of Bmal1 mRNA degradation 0.3 0.3 0.3 0.3 38
VmC(nM·h
-
1)
Maximum rate of Myod1 mRNA degradation 0.12 0.12 0.12 0.12 38
Vd(nM·h
-1) Maximum rate of P2 degradation 1.5 1.5 1.5 1.5 24
vstot(nM·h
-
1)
Maximum transcription rate 1.0 1.0 1.0 1.0 38
VsB(nM·h
-1) Maximum rate of Bmal1 mRNA synthesis 0.28vstot 0.28vstot 0.28vstot 0.28vstot 38
VsC(nM·h
-1) Maximum rate of Myod1 mRNA synthesis 0.95vstot 0.95vstot 0.95vstot 0.95vstot 38
VsM(nM·h
-1) Maximum rate of miR-206 synthesis 1.0 1.0 1.0 1.0 24, 38
Vs(nM·h
-1) Maximum rate of Clock mRNA synthesis 0.5 0.5 0.5 0.5 24
Vm(nM·h
-1) Maximum rate of Clock mRNA degradation 0.3 0.3 0.3 0.3 24
C1(nM·h
-1) Rate constant for the production of the miR-206 0.01 0.01 0.01 0.01 43
C2(h
-1) Maximum rate of miR-206 degradation 0.01 0.01 0.01 0.01 43
C3(nM
-1·h
-
1)
Rate constant for the formation of the RISC complex 0 0.5 1.0 1.5 43
C4(h
-1) Maximum rate of RISC complex degradation 0.6 0.6 0.6 0.6 43
The sets 1, 2, 3 and 4 represent the cases for the RISC formation rate C3 = 0, 0.5, 1.0 and 1.5 nM
-1·h
-1, respectively. The oscillation periods of the four parameter
sets are 24.6, 23.8, 24 and 24.04 h respectively. The parameter set 3 was selected because the circadian oscillation period is consistent with the physiologic
phenomenon.
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transcription, like the one caused by the myod1 gene,
results in only a modest increase in Myod1 mRNA
abundance and probably an even more modest increase
in the translated protein.
From the above results, three interesting findings are
presented: 1) Although the miR-206 regulation is crucial
in controlling the dynamics of the circadian rhythms
system, it is not strong and fits exactly some recent data
demonstrating that a Drosophila miRNA can function
as a buffering agent against the environmental perturba-
tions during the development [42]. 2) Sustained oscilla-
tions with a circadian period close to 24 h occur in our
model in the continuous darkness, which is precisely
regulated by the interlocked positive and negative feed-
back loops. And these loops effectively maintain the
oscillations and the stability of the system, as indicated
by the small variation in the amplitude of several key
components (such as the MP, MB, P0, P2, PN and IN).
But the expression levels of cytosolic CLOCK proteins,
M y o d 1m R N Aa n dc y t o s o l i cM Y O D 1a r el a r g e l y
enhanced in the absence of miRNA, reflecting the fact
that the complex IN’s direct effects on the Mmy and
MYC expression is more important than the indirect
miRNA regulation. These observations may provide a
plausible mechanism through which tissue-specific fac-
tors such as Myod1 and miR-206 can convey unique tis-
sue requirements to the circadian clock. 3) Once again,
it is confirmed that miR-206 is necessary for accurate
circadian timekeeping, since in the absence of miRNA,
the oscillation period of the system as shown by the
three representative components, Bmal1, Myod1 and
Clock mRNAs and their corresponding proteins is not
very constant and changes with time. At 48 h, the per-
iod is 24.5 h. But when the simulation time increases to
300 h, the period has changed up to ~24.6 h, and even
up to ~24.7 h at 1000 h or much longer time. However
the system is more stable in the presence of miRNA
when the period of the oscillatory system is always 24.0
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Figure 1 Circadian oscillations in constant darkness. (A, C and E) Time evolution of the mRNAs of Bmal1 (MB), Myod1 (Mmy) and Clock (MP).
(B, D and F) Corresponding oscillations of the total amounts of BMAL1, MYOD1 and CLOCK proteins. The red and black curves show the
oscillations with or without the regulation of miR-206, respectively.
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Figure 2 The expression proportion of key components in the
pathways with miR-206 mediation to that without miR-206
mediation.
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plays in the accurate circadian timekeeping.
Dynamic sensitivity analysis
Having many successfully applications in the study of
biochemical systems [27,43], sensitivity analysis provides
a systematic framework to investigate how changes of a
parameter cause changes of the dynamic behavior of a
pathway, and which parameters are the most crucial
ones impacting the whole system. In the present work, a
sensitivity analysis for all parameters (Table 1) of the
mammalian circadian pathway mediated by miR-206
was conducted, when a total of 3724 (76 rate constants
× 49 reactions) local sensitivities were calculated and
normalized with 288 scaled sensitivity absolute values (|
S|). As a result, 47 rate constants are found larger than
0.9, where negative S indicates that the reaction output
decreases with the increasing rate constant. In Figure
3A, only those reactions or parameters with significant
effects as revealed by the sensitivity analysis on the sys-
tem are shown, and others with weak or no influences
(|S| < 1) on the pathway were omitted for clarity.
The rate of Bmal1 mRNA synthesis (VsB) has the lar-
gest impact on the whole system, affecting 21 out of the
total 49 reactions while VmB significantly affects 20 reac-
tions, KsB affects 14 reactions, and V1B,V 3B and KI
respectively affecting 13 reactions (Figure 3). These
observations indicate that the impact of these para-
meters on the whole pathway are in the order of VsB
>VmB >KsB >V1B >V3B >KI. Thus, we may conclude that
Figure 3 The heat maps of local sensitivities of each reaction flux with respect to each parameter. Each column represents a parameter,
and each row represents a single reaction flux. Reactions R1-R24 represent the Bmal1 mRNA formation, Bmal1 mRNA degradation, cytosolic
BMAL1 formation, cytosolic BMAL1 phosphorylation, cytosolic BMAL1 dephosphorylation, cytosolic BMAL1 nonspecific degradation, cytosolic
phosphorylated BMAL1 degradation, cytosolic phosphorylated BMAL1 nonspecific degradation, BMAL1 protein entry into the nucleus, BMAL1
protein exit from the nucleus, nuclear BMAL1 nonspecific degradation, nuclear BMAL1 phosphorylation, nuclear BMAL1 dephosphorylation,
nuclear phosphorylated BMAL1 degradation, Myod1 mRNA formation, Bmal1 mRNA nonspecific degradation, Myod1 mRNA degradation, Myod1
mRNA nonspecific degradation, MYOD1 formation, cytosolic MYOD1 phosphorylation, cytosolic MYOD1 dephosphorylation, cytosolic MYOD1
degradation, cytosolic phosphorylated MYOD1 degradation, cytosolic phosphorylated MYOD1 nonspecific degradation, respectively. Reactions
R37-R45 represent the miR-206 formation, RISC complex formation, miR-206 degradation, RISC complex degradation, IN complex formation, IN
complex dissociation, IN complex degradation, IN complex nonspecific degradation and nuclear phosphorylated BMAL1 nonspecific degradation,
respectively. The explanation of the parameters in each column can be seen in Table 1.
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Page 7 of 17the parameters with respect to the synthesis and degra-
dation of BMAL1 and its mRNA exert a marked effect
on producing sustained oscillations. In other words, the
clock mechanism is highly sensitive to BMAL1. This
might be a result of the critical role of BMAL1 promot-
ing the circadian periodicity of the transcriptional acti-
vation, since it takes shape a positive branch of the
main transcriptional autoregulatory feedback loop.
In addition, another interesting finding is that para-
meter C1 which relates to the production of miR-206
affects 4 reactions of all 49 reactions with |S| = 1. This
positively shows the importance of miR-206 in regulat-
ing the whole system. Figure 3B depicts this result by
the red region that represents the influence of C1 on the
model. The small value of the sensitivity indices (|S| =
1) reflects a fact that miRNA though regulating the sys-
tem in a relatively weak manner, is still crucial in con-
trolling the dynamics of the circadian clock.
As we know, sustained oscillations only occur within
an appropriate range of parameter values, and beyond
this range the system tends to reach a steady state. Such
an evolution is often associated with the occurrence of
damped oscillations. The mammalian circadian system
is thought to be composed of a hierarchical set of oscil-
lators with the suprachiasmatic nuclei acting as a master
pacemaker [2,44] which is independently able to both
generate and sustain its own circadian oscillations. The
peripheral tissues can give rise to circadian rhythms and
these peripheral rhythms also appear to be sustained
[45]. Peripheral rhythms are damped unless they are dri-
ven by periodic signals received from the SCN [46,47].
The oscillations can readily be entrained by the periodic
variation of the parameter when damped oscillations
o c c u ri nt h em o d e li nc o n t i nuous darkness [31]. All
these observations can be found in the present model in
Figure 4, which displays the time evolution curves of Bn,
MP, PN and MiR-206. These curves were obtained when
C1 =0 . 2 3n M · h
-1 and all other parameters remained as
the same values as in Figure 1.
The effect of parameter on model dynamics
As a starting point to examine how the synthesis rate of
Bmal1 mRNA (VsB) exhibits the largest effects on our
system, some explorations on variation of the parameter
space were carried out presently. The value of VsB was
changed as 0.14, 0.28 (physiological value) and 0.56
nM·h
-1, when values of other parameters were kept
fixed. Figure 5 shows the obtained results where the
blue, red and black curves represent the cases when VsB
= 0.14, 0.28 and 0.56 nM·h
-1, respectively. When VsB
decreases from 0.28 to 0.14 nM·h
-1, the oscillations of
Bmal1 mRNA (Figure 5A) and Myod1 mRNA (Figure
5B) vanish and subsequently evolve toward a steady
state. The oscillation amplitude of Clock mRNA (Figure
5C) decreases accompanied with the increase of the
oscillation frequency. However, as VsB increases to 0.56
nM·h
-1, an unequal amplitude of oscillation occurs for
Bmal1 mRNA with a decreasing oscillation period com-
pared to the ‘basal’ value of VsB = 0.28nM·h
-1 (Figure
5A). Since VsB is the synthesis rate of Bmal1 mRNA, the
amplitude of oscillation increases when VsB rises to 0.56
nM·h
-1. The reason for the occurrence of unequal
amplitude of oscillation for Bmal1 mRNA might be due
to the negative feedback control on the Bmal1 mRNA
production from the downstream gene like IN complex
(see Figure 10 in the latter part). But VsB plays an indir-
ect role for the Myod1 mRNA production. This also
explains why Myod1 mRNA oscillates in an equal
amplitude and in a constant period in regard to VsB =
0.28 nM·h
-1 (Figure 5B), since there is no any negative
feedback for the Myod1 mRNA (see Figure 10 in the
latter part).
In contrast, the oscillation of Clock mRNA keeps con-
stant with only slight variations occurring in the ampli-
tude and period with the change of VsB (Figure 5C).
This is consistent with the Clock expression dynamics
to maintain normal circadian rhythmicity [48]. A more
interesting finding here is that the system still generates
sustained oscillation even when VsB value is whether
enlarged or lessened (from 0.1 to 3.0), indicating that
the Clock is robust to the variations of VsB. This on one
hand might explain why the biological clock period is
always constant in various organisms, and on the other
hand is also consistent with the fact that the Clock
expression is necessary to maintain the normal circadian
rhythmicity [48]. Clearly, the robustness of the CLOCK
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Figure 4 Damped oscillations that occur in the model in
continuous darkness. The curves showing the time evolution of
Bn, MP, PN and MiR-206 were obtained when C1 = 0.23 nM·h
-1 while
other parameters kept the same basal values as used in Figure 1.
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Page 8 of 17protein would play a crucial role in a living system to
keep its normal physiological functions, since the devel-
oped biological clocks from evolution in animals, plants
and others are important in regulating and coordinating
the internal biological processes [49].
Figure 6 shows how the frequency and amplitude of
the oscillations for Bmal1, Myod1 and Clock mRNAs
vary with the increase of VsB value when keeping all
other rate constants fixed (Figure 6). The black, blue,
and red curves correspond to the Bmal1 mRNA, Myod1
mRNA and Clock mRNA, respectively. The oscillation
of Bmal1 and Myod1 mRNAs disappears and the system
evolves toward a stable state when VsB ≤ 0.25 nM·h
1
(Figure 6A). In other words, the period and amplitude
of the oscillation in regard to the two mRNAs equal 0, i.
e., their frequency tends to infinity in this case. How-
ever, when VsB >0 . 2 5n M · h
-1, the frequency of oscilla-
tion related to Bmal1 mRNA becomes stable while the
frequency of oscillation related to Myod1 mRNA
declines sharply. The frequency of Clock mRNA also
decreases with the increase of VsB. The amplitude of
oscillation for Bmal1 and Myod1 mRNAs tends to
increase, while there is only a marginal change in the
amplitude with regard to Clock mRNA (Figure 6B). All
the above data not only show the significant roles of
parameter VsB in the whole system, but also prove the
robustness of the clock mechanism to system perturba-
tions, which might be due to a direct and negative auto-
regulation in the dynamic system.
The effect of parameter variation of miRNA
Previous research suggested that miR-206 is specifically
expressed in skeletal muscle [50], which is a clock-con-
trolled gene that plays a role in regulating the peripheral
circadian rhythm. The sensitivity analysis here also
shows that the system is sensitive to the variation of the
miR-206 production rate (C1). Therefore, an attempt has
been made to investigate how the changes of the kinetic
parameters associated with miR-206 cause changes in
the dynamic behavior of the biological clock system.
It is also interesting to explore the variation of the fre-
quency and amplitude when C1 was set to 0.0, 0.01 and
1.0 nM·h
-1, with all other rate constants kept fixed. The
obtained results are shown in Figure 7, in which the
blue curves represent the variation of Bmal1 mRNA,
M y o d 1m R N Aa n dC l o c km R N Ai nt h ea b s e n c eo f
miRNA (as shown in Figures 7A, B and 7C, respec-
tively). The red and black curves represent the
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Page 9 of 17conditions when C1 =0 . 0 1a n d1 . 0n M · h
-1 respectively.
As seen from this figure, when C1 = 0.0 nM·h
-1, the sys-
tem still keeps relatively constant oscillations in the
absence of miRNA, which might indicate that the regu-
lation of miR-206 in the biological clock system is
relatively weak [51]. But once the miR-206 is introduced
(C1 =0 . 0 1n M · h
-1), the oscillatory behavior of the sys-
tem appears in an extremely constant manner. When C1
changes from 0.0 to 0.01 nM·h
1, the amplitudes of oscil-
lation for Bmal1 and Clock mRNAs do not show any
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Figure 6 Effect of the variation of the maximum degradation rate of Bmal1 mRNA (VsB nM·h
-1)o nt h em o d e l . Variation of (A) the
frequency and (B) the amplitude of oscillation in the model as a function of VsB (nM·h
-1). Bmal1 mRNA, Myod1 mRNA and Clock mRNA are
shown in black, blue and red, respectively.
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Page 10 of 17significant changes, but the amplitude of oscillation for
Myod1 mRNA decreases from 0.5 to 0.3 nM. The rea-
son is that Myod1 directly activates the expression level
of miR-206, thus resulting in the difference of expres-
sions between Bmal1 and Myod1. All these results
reveal that the sustained oscillations occur only within a
certain range of parameter values. Beyond this range,
the system tends to a steady state. So when more
miRNA is produced (C1 =1n M · h
-1) in the system, all
t h ea b o v et h r e em R N A se v o l v et oas t e a d ys t a t ea n dn o
oscillations occur. Clearly the over expression of miR-
206 in the system disturbs the biological clock and
makes the periodic oscillations collapsed. This result
indicates that miRNAs are important in maintaining the
tissue and cell normal function, and the abnormal
expression of miRNAs may lead to unexpected diseases.
In the next step, we carried out a detailed analysis to
uncover how the system is affected by miR-206, when the
amplitude and the frequency of oscillation for the above
three representative components are calculated. Bmal1
mRNA, Myod1 mRNA and Clock mRNA are shown in
black, blue and red in Figure 8, respectively. The results
show that the frequencies of oscillation for all three
mRNAs increase with the increase of C1, indicating that
the temporal sequence of the gene production can be
interfered (Figure 8A). The amplitudes of oscillation for
Bmal1 and Myod1 mRNAs are almost constant and no
significant changes are found though C1 has been changed
from 0 to 0.1 nM·h
-1. However, the Clock mRNA
expression decreases by about 4 times (Figure 8B). This
reduction in amplitude of the oscillation shows that the
expression level of Clock mRNA can be affected when C1
increases. These results show that miR-206 may be a stabi-
lizing factor on the frequency and amplitude of the oscilla-
tor system, thereby regulating the dynamics of the protein
production and gene expression.
In addition, the effects of the variation of parameters C2
(the degradation rate of the miR-206), C3 (the formation
rate of the RISC complex), C4 (the maximum degradation
rate of the RISC complex) and KsC (the synthesis rate of
MYOD1) on the whole system are also investigated,
respectively. Figure 9 shows the obtained results. As can
be seen, when parameters C2 and C3 are increased by 10
folds compared to their normal values (Table 1), very
small variations are observed for all three representative
molecules, i.e., Bmal1 mRNA, Myod1 mRNA and Clock
mRNA. Interestingly, the changes for other two para-
meters (C4 and KsC) also do not significantly affect the sys-
tem, and the observed evolutionary curves with different
parameter values are almost totally overlapped with each
other. These results demonstrate that all the four para-
meters are not as significant as C1, the miRNA production
rate, to the oscillator system, which is consistent with the
findings obtained from the sensitivity analysis.
Conclusion
MiRNAs play an important role in various biological
functions and represent a potentially novel avenue by
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Page 11 of 17which biological timing processes can be regulated. In
this paper, the dynamics of regulation by miR-206 were
investigated based on the Clock-Myod1-miR-206 inter-
acting positive and negative feedback loops controlling
the timing of the circadian cycle in mammalian skeletal
m u s c l e .T ot h i se n d ,as y s t e m - t h e o r e t i ca p p r o a c hb y
using Hill-type terms, Michaelis-Menten type and mass
action kinetics is introduced in this work and the
dynamics is implemented deterministically. The model
outlined presently not only introduces miR-206 into the
field of circadian timing, but also accurately predicts the
clock periodicity and clock entrainment. A sustained
periodic circadian oscillation occurs in the circadian
clock system when the series of parameters were set
with biologically reasonable values. In addition, this
model reveals the possible existence of multiple sources
of biological oscillatory behavior, and provides a plausi-
ble mechanism through which tissue-specific factors
such as Myod1 and miR-206 can convey unique tissue
requirements to the circadian clock. In addition, the
results point out the important effects of parameter var-
iations such as the miR-206 synthesis on the regulation
of the mammalian clock system, which not only changes
the amplitude but also alters the frequency of the oscil-
lations of the deterministic system. In other words, miR-
206 plays a significant role on the dynamics of regula-
tory systems, both by affecting the level of the gene
expression and by interfering with the temporal
sequence of the gene production or transmission.
In short, the essential qualitative features of these
results indicate that the miRNA regulation may be one
of the primary means for controlling the period of oscil-
latory molecules and biochemical pathways within mam-
malian circadian clock. We provide testable hypothesis
for experimental biologists to further investigate miR-
NA’s functional roles in regulating cellular processes
and development. The challenge for future studies will
be a focus on the modulation of the miRNA expression
as a potentially powerful diagnostic and therapeutic
approach to treat cardiac and skeletal muscle disease.
Methods
Model description
In this work, a model of the mammalian circadian core
oscillator which is mediated by miRNA was developed,
using a series of ordinary differential equations (ODEs)
(Figure 10). The focus is put specifically on the essential
structure of the molecular network to characterize the
role of the positive and negative feedback loops regu-
lated by miR-206.
Evidence to support the model is as follows:
1) In the cell nucleus, the genes of Myod1 and Bmal1
are transcribed into the corresponding Myod1 and
Bmal1 mRNAs (denoted Mmy and MB). Then these
mRNAs are transported to the cytoplasm and degraded.
2) In the cytoplasm, the two mRNAs are translated
into unphosphorylated proteins, i.e., the MYOD1 and
BMAL1 (denoted by MYC and Bc).
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Page 12 of 173) These unphosphorylated proteins further undergo
reversible phosphorylation (with phosphorylated forms
denoted by MYcp and Bcp) and degradation processes.
4) The cytosolic BMAL1 protein is reversibly trans-
ported into the nucleus. In turn, the nuclear BMAL1
protein proceeds reversible phosphorylation and then
degrades in nucleus (with unphosphorylated and phos-
phorylated BMAL1 denoted by Bn and Bnp, respectively).
5) The model also incorporates the Clock gene tran-
scription, i.e., the Clock mRNA (MP), which transports
into the cytoplasm where it is then translated into the
CLOCK protein (P0) and degrades. In the cytoplasm, the
CLOCK protein can be reversibly phosphorylated from
the form of P0 into P1 and P2, successively.
6) The latter form P2 is degraded and transported into
the nucleus (PN), and the nuclear form of protein PN
subsequently represses its gene expression and produces
a negative feedback control loop (Figure 10, Loop 2)
[24]. Because the expression of Clock is considered to
be constitutive and give rise to a high, constant level of
cytosolic and nuclear CLOCK proteins [52], we assume
that once entering the nucleus, the unphosphorylated
BMAL1 immediately forms a complex with the Clock
[40] (the complex is denoted by IN).
7) In the nucleus, the BMAL1-CLOCK heterodimer
increases the rate of transcription of the corresponding
gene, Myod1 [53]. At the same time, it represses the
transcription of Bmal1 gene through exerting a negative
autoregulation on the pathway (Figure 10, Loop 1) [54],
and this regulatory effect of BMAL1 is described as a
direct and negative autoregulation type.
8) In turn, the Myod1 gene, which is known to regulate
the miR-206 expression [23] has been shown to drive the
expression of the primary miR-206 transcript AK132542,
leading to increased expression of miR-206 [22]. And miR-
206 subsequently represses the expression of Clock by
binding to the Clock mRNA and forms the complex RNA-
induced silence complex (RISC) and then degrades [32].
In summary, this model displays the essential compo-
nents and characteristics of the circadian clock, and pro-
vides a plausible mechanism through which the tissue-
specific factors such as Myod1 and miR-206 can convey
unique tissue requirements to the circadian clock. The
detailed pathway is shown in Figure 10.
Rate equations
Deterministic models based on ODEs can provide
insights into the understanding of the biological
Figure 10 A Clock-Myod1-miR-206 feedback loop controlling the timing of the circadian cycle in skeletal muscle. The subscripts c, n, cp
and np of the symbols represent for cytosolic, nuclear, cytosolic phosphorylated and nuclear phosphorylated, respectively.
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Page 13 of 17pathway, as how the overall behaviors depend on a set
of constituent reactions. The whole circadian clock
p a t h w a yi sm o d e l e du s i n gas e to fO D E sw h i c hw e r e
numerically solved by stiff method. The variables of the
system represent the concentrations of each species like
mRNAs or proteins (Figure 10).
In this paper, we develop a detailed distinctly dynamic
model of the mammalian circadian clock mediated by
miR-206 by using Hill-type terms, Michaelis-Menten
type and mass action kinetics, which are the mathemati-
cal models that explain and predict the behaviors of the
molecules in dynamic equilibrium. The time evolution
of the model is governed by a system of 19 kinetic
Equations (1)-(19). The ODEs of the dynamic model are
expressed as follows:
(a) genes of Bmal1, Clock and Myod1:
d([Bmal1])
dt
= d1 − d2 [Bmal 1] − VsB
KIB
m1
KIB
m1 + [IN]
m1(1)
d([Clock])
dt
= d5 − d6[Clock] − Vs
KI
m2
KI
m2 + [PN]
m2 (2)
Although Eqs. (1) and (2) are applied for different
genes, the underlying principles and formulations are
similar: the first two terms represent the generation and
degradation of given genes, while the last one represents
the inhibition of gene transcription by the negative feed-
back control [35,55].
d([Myod1])
dt
= d3 − d4[Myod1] − VsC
[IN]
n1
KAC
n1 + [IN]
n1 (3)
In Eq. (3), the first two terms are the same to Eqs. (1)
and (2). The last term represents the activation of the
gene transcription by the complex IN [52].
(b) mRNAs of Bmal1, Myod1 and Clock:
d([MB])
dt
= VsB
KIB
m1
KIB
m1 +[ IN]
m1 − VmB
[MB]
KmB +[ MB]
−kdmd[MB]
(4)
d([Mmy])
dt
= VsC
[IN]
n1
KAC
n1 +[ IN]
n1 − VmC
[Mmy]
KmC +[ Mmy]
−kdmc[Mmy]
(5)
We define MB and Mmy as the concentrations of
mRNA product at time t, and then the variations of the
two mRNAs with time are summarized by Eqs. (4) and
(5). The two equations describe the synthesis, maximum
degradation and nonspecific degradation of the Bmal1
mRNA and Myod1 mRNA, respectively.
d([MP])
dt
= Vs
KI
m2
K
m2
I +[ PN]
m2 − Vm
[MP]
Km +[ MP]
−C3 [miR -2 0 6 ][ MP]
(6)
The first two terms in Eq. (6) are similar to Eq. (5) by
representing the production and degradation of MP (the
mRNA of Clock). The third term represents the forma-
tion of the miR-206-MP (RISC) complex.
(c) reversibly phosphorylated and non-phosphorylated
proteins MYOD1 in the cytoplasm:
d([MYC])
dt
= −V1C
[MYC]
Kp3 +[ MYC]
+ V2C
[MYCP]
kdp3 +[ MYCP]
−kdnc[MYC]+ksC[Mmy]
(7)
d([MYcp])
dt
= V1C
[MYc]
Kp3 +[ MYc]
− V2C
[MYcp]
Kdp3 +[ MYcp]
−kdn4[MYcp] − VdCC
[MYcp]
kd3 +[ MYcp]
(8)
where the phosphorylation and dephosphorylation in
the first two terms of each equation are governed by the
Michaelis-Menten kinetics. The third term in above two
equations represents the nonspecific degradation of the
non-phosphorylated and phosphorylated cytosolic
MYOD1s, respectively. The last term in Eq. (7) repre-
sents the synthesis of the cytosolic MYOD1, while in
Eq. (8) represents the maximum degradation of the
phosphorylated cytosolic MYOD1 using the Michaelis-
Menten kinetics, respectively.
(d) phosphorylated and non-phosphorylated proteins
BMAL1 and CLOCK in the cytoplasm and nucleus:
d([Bn])
dt
= −V3B
[Bn]
Kp2 +[ Bn]
+ V4B
[Bnp]
Kdp2 +[ Bnp]
+k1[Bc]+k4[IN] − k3[PN][Bn]
−k2[Bn] − kdn3[Bn]
(9)
d([Bc])
dt
= −V1B
[Bc]
Kp1 +[ Bc]
+ V2B
[Bcp]
Kdp1 +[ Bcp]
+ksB[MB]+k2[Bn]
−k1[Bc] − kdn1[Bc]
(10)
These two equations describe the synthesis and degra-
dation of the cytosolic and nuclear BMAL1 proteins,
respectively. The first two terms are similar to Eqs. (7)
and (8), while the remaining terms correspond to the
synthesis or degradation of the proteins by using the
mass action rules.
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dt
= V1B
[Bc]
Kp1 +[ Bc]
− V2B
[Bcp]
Kdp1 +[ Bcp]
−kdn2[Bcp] − VdBC
[Bcp]
Kd1 +[ Bcp]
(11)
d([Bnp])
dt
= V3B
[Bn]
Kp2 +[ Bn]
− V4B
[Bnp]
KdP2 +[ Bnp]
−kdn6[Bnp] − VdBN
[Bnp]
Kd2 +[ Bnp]
(12)
Eqs. (11) and (12) describe the synthesis and degrada-
tion of the phosphorylated cytosolic or nucleus BMAL1
proteins, respectively. The principles for the two equa-
tions are the same as Eq. (8).
d([P0])
dt
= ks[MP] − V1
[P0]
K1 + [P0]
+ V2
[P1]
K2 + [P1]
(13)
d([P1])
dt
= V1
[P0]
K2 +[ P0]
− V2
[P1]
K2 +[ P1]
−V3
[P1]
K3 + [P1]
+ V4
[P2]
K4 + [P2]
(14)
d([P2])
dt
= −Vd
[P2]
Kvd +[ P2]
+ V3
[P1]
K3 +[ P1]
−V4
[P2]
K4 + [P2]
+ k6[PN] − k5[P2]
(15)
d([PN])
dt
= −k6[PN]+k5[P2]
+k4[IN] − k3[PN][Bn]
(16)
Equations (13)-(15) relate to the synthesis and degra-
dation of phosphorylated and non-phosphorylated
cytosolic CLOCK proteins. Eq. (16) refers to the varia-
tion of the concentration of nucleus CLOCK protein
with time. The principles are similar to the above
equations.
(e) BMAL1- CLOCK complex in nucleus:
d([IN])
dt
= k3[PN][Bn] − k4[IN]
−VdIN
[IN]
Kd4 + [IN]
− kdn5[IN]
(17)
where the first term corresponds to the synthesis of
complex IN, while the last three terms represent the dis-
sociation, maximum degradation and nonspecific degra-
dation of IN, respectively.
(f) miR-206 and RISC:
d([miR - 206])
dt
=

VsM
[MYC]
n2
KAM
n2 +[ MYC]
n2 + C1

−C2[miR -2 0 6 ] − C3[miR -2 0 6 ][MP]
(18)
d([RISC])
dt
= C3[miR - 206][MP] − C4[RISC] (19)
The concentration change of miR-206 is given by Eq.
(18) and that for RISC is given by Eq. (19). These two
equations are similar in that they describe the synthesis
and degradation of miR-206 and RISC respectively, but
different in that the synthesis of miR-206 is described
by the Hill-type function.
The definition of all the parameters in Eqs. (1)-(19) is
shown in Table 1. The concentrations of all species are
defined with respect to the total cell volume, which is
denoted by the subscripts of c, n, cp or np for the cyto-
solic, nuclear, cytosolic phosphorylated or nuclear phos-
phorylated terms, respectively.
Dynamic sensitivity analysis
The definition of sensitivity analysis (SA)i st h a tSA stu-
dies the relationships between the information flowing
in and out of a model. It is a step in the modeling pro-
cess aiming at identifying the important uncertainties
for the purpose of prioritizing the additional data collec-
tion or research. It is used to determine how “sensitive”
a model is to those changes occurring in the parameter
values or in the structure of the model. A dynamic sen-
sitivity value reflects a relative relationship between the
magnitudes of a parameter (input) and a state variable
(output) at any time. Thus, the measure of the sensitiv-
ity is that the sensitivity of an item is taken to be the
output with respect to a single parameter Xi:
SA =
∂Y
∂Xi
(20)
The quantity SA is the local sensitivity index of the
state variable Y (output) relative to the parameter Xi,
and the sensitivity of each variable corresponds to a spe-
cified parameter. In order to obtain the scaled sensitivity
coefficient SA that is dimensionless and plotted for
maintaining the visual presentation drawing, the results
are normalized.
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